What Inflation? The Super Frugal Say They Were Made for This Moment
For families with strong habits to curb spending, sticking to their strict household budget is the plan.Read More
Crypto Bankruptcy Could Be Investors’ Nightmare
The cryptocurrency market’s latest swoon has raised the specter of bankruptcy restructuring. In such a case, crypto investors would be navigating uncharted territory.Read More
Crypto Hedge Fund Three Arrows Capital Considers Asset Sales, Bailout
Firm’s founders say they still believe in the future of cryptocurrenciesRead More
Putin lambasts the West and declares the end of ‘the era of the unipolar world’
Russian President Vladimir Putin’s much-hyped speech at St. Petersburg International Economic Forum was delayed on Friday after a “massive” cyberattack, the Kremlin has announced. Read More
Opinion: Mike Pence, come to your senses
On Thursday, as the January 6 hearings entered their third day, two things were made clear: former Vice President Mike Pence pushed back privately on former President Donald Trump’s attempts to invalidate the results of a free and fair election, but he did not publicly speak out at the time, and Trump seemed perfectly fine […]
Markets Post Tentative Gains After a Week of Deep Losses
Stocks rose on Friday, regaining some ground at the end of a tumultuous week in which Wall Street slipped into a bear market. Follow business updates.Read More
Santander Picks Insider as Next CEO
The Spanish bank named its head of Mexico and North America operations as its new chief executive, as it braces for a period of economic uncertainty.Read More
Stephen Curry Left His Critics With Nothing Else to Say
Four N.B.A. championships. Two Most Valuable Player Awards. And yes, a finals M.V.P. Golden State’s Curry has nothing else to prove.Read More
Walmart-Amazon Battle Royale Heats Up in India
Walmart-owned Flipkart’s rapid expansion in the world’s second-most-populous nation looks firmly pointed at Amazon ahead of a possible IPO next year.Read More
Drug Pricing Debate in Washington Is a Headache for Pharma
A last-ditch effort by Democrats to pass a slimmed-down version of Build Back Better could include measures on drug pricing, putting pressure on the pharma sector.Read More
